Cardio Clinical

Cardio Clinical exists of 1300 hospitals in 27 different countries, enabling us to provide sites and expertise around the world. The network has been involved in various large-scale randomized intervention trials relating to the prevention and treatment of cardiovascular disease and has extensive experienced staff in performing such trials.

All parties involved in the Cardio Clinical share a common goal of reducing the burden of cardiovascular disease, which remains the leading causes of death globally in the last 15 years. With Cardio Clinical, Julius Clinical has access to pioneering expertise and capabilities for cardiovascular research and trials. This will, in turn, support the pharmaceutical industry in developing drugs and running trials that will have the greatest impact on the cardiological health of millions of people around the world.

FOR SITES

CardioNET is a large global network consisting of cardiologists and researchers focusing on the development of novel therapies for Cardiovascular Diseases, mainly lipid lowering cardiovascular intervention trials, stroke prevention and heart failure. The network is based on solid and long collaborations with

If you wish to be more engaged in clinical research activities, enhance your patients’ care and further develop your practice, please consider joining Cardio Clinical*.

CardioNET is a large global network consisting of cardiologists and researchers focusing on the development of novel therapies for Cardiovascular Diseases, mainly lipid lowering cardiovascular intervention trials, stroke prevention and heart failure. The network is based on solid and long collaborations with

*Get in contact by filling in the contact form at the bottom of this page.

FOR SPONSORS

  • Access to high performing sites other CROs have no access to
    • Cardio Clinical provides access to over 1700 hospitals in 29 countries with years of experience in many cardiovascular trials
  • Substantial experience in operating large collaborative and international collaborations
  • Our peer-to-peer network ensures higher recruitment and retention of patients
  • Recently executed contract with majority of sites à shorter timelines
  • Up to date knowledge on submission requirements (do it right the first time)
  • Experienced staff available that have already managed these sites, and have proven to work well with them

EXPERIENCE

Whether your study involves specific clinical trial phases, an investigator-initiated trial, observational study or custom or tailor-made trial, we have years of experience in clinical trials and the expertise you need wherever it’s required – including at short notice – whatever the therapeutic area in question. The trials conducted with the expertise of the PCRN, are:

ONGOING TRIALS

COVID-RED

Therap. Area     Infectious Diseases

# of Patients    16,500

Research           Early detection of COVID-19

Status                Ongoing

DISCOVER

Therap. Area   Diabetes Mellitus

# of Patients    9,650

Research           Metabolic Diseases

Duration           2016 –

Status                Ongoing

CLEAR

Therap. Area   Cardiovascular Diseases

# of Patients    2,161

Research          Cardiovascular Risk Factors

Status                Ongoing

RSV Elderly

Therap. Area   Infectious Diseases

# of Patients    500

Research           Respiratory Syncytial Virus (RSV) Infections

Status                 Ongoing

FINISHED TRIALS

CAPiTA

Therap. Area   Infectious Diseases

# of Patients    84,496

Research           Pneumonia

Duration           2008 – 2014

Status                Finished

DISCOVER

Therap. Area   Metabolic Diseases

# of Patients    137

Research          Type 2 Diabetes

Duration           2016 – 2019

Status                Finished

Nestle

Therap. Area   Gastrointestinal

# of Patients    128

Duration           2014 – 2015

Status                Finished

Intrepid

Therap. Area  Respiratory Diseases

Research          Obstructive Pulmonary Disease

Duration           2018 – 2020

Status                Finished

QHD

Therap. Area   Infectious Diseases

# of Patients    344

Research           Influenza A Virus

Duration           2019 – 2020

Status                Finished

OUR SERVICES

  • Central coordination and execution by Julius Clinical of:
    • Site selection and initiation
    • Streamlining contracting and payments
    • All trainings (GCP, study specific)
    • Data management
    • Monitoring
    • Conducting close out visits
    • Feasibility data from PCRN
  • Input from safety physicians and science team on protocol
  • GPs act as site investigator
  • GPs can recruit healthy volunteers for other research sites

OUR EXPERT TEAM

A key strength of Julius Clinical is the academic expertise and integrity of our scientific team. Our scientific leaders have broad experience on study committees and are able, through their contacts, to bring together and work effectively with international networks of thought leaders. Our scientific team:

PROF. DIEDERICK E. GROBBEE

Chief Scientific Officer

LEYLA KRAGTEN-TABATABAIE, PhD.

Director Scientific networks

JON BOUWMAN

Associate Director SMO

TITIA LEURINK

Manager SMO Projects

PROF. JOOST HOEKSTRA

Clinical diabetology specialist

DR. MARCO ALINGS

Cardiologist / electrophysiologist

M. CASTRO CABEZAS, PhD

Internist-endocrinologist/ vascular specialist

SCIENTIFIC INSIGHTS

Education, motivation and quality have priority at Julius Clinical. For this reason, we offer accredited continuing education, so that all parties involved are well informed of developments in the field of scientific research in the primary care setting.

Research results are linked back, including via accredited continuing education and newsletters. If necessary or desired, we also offer education prior to a new study. Continuing education activities are currently mainly focused on general practitioners, nurse practitioners, practice assistants and pharmacists.

We organise continuing education and events in conjunction with our partners Elevate and PAO-H.